Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | New Report Analyses Therapeutic Proteins for Assisted Reproductive TechnologyPiribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report providing an analysis in the development pipeline of novel recombinant...
By: Jonna Dagliden “FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART) Competitor Analysis”, which is available from tinyurl.com/ The report shows that FSH is used to induce development of multiple follicles in ovulatory women and anovulatory infertile women. The major recombinant FSH products posted 2008 sales of $ 1.25 bln. Authors of the report note that current recombinant (follitropin) Current focus of new development lies on longer-acting and needle-free preparations. The most advanced projects are in registration or late clinical development. Other innovations in FSH research and development are modern production technologies in new expression systems such as plants or transgenic animals. The search for more effective FSH is ongoing and oral FSH receptor agonists have been identified. The report describes the market size of major FSH products, provides information on the marketed FSH, hCG and LH preparations and includes a compilation of current active projects in research and development of novel FSH, LH and hCG receptor agonists. Competitor projects are listed in a tabular format providing information on: *Drug Codes, *Target / Mechanism of Action, *Class of Compound, *Company, *Product Category, *Indication, *R&D Stage and *additional comments with a hyperlink leading to the source of information. “FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART) Competitor Analysis” is available from Piribo. For more information go to: http://www.piribo.com/ Piribo product ID: LME00109 # # # About Piribo. Piribo (http://www.piribo.com/ End
|
|